Predictors of Vitrectomy Outcomes in Myopic Foveoschisis
Key facts
- Who runs it
- Singapore National Eye Centre
- Where
- Singapore1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 30 people, planned
- Started
- 10 Jun 2024
- Expected to end
- 10 Jun 2029
- Type of study
- InterventionalOne group gets an existing treatment, for comparison.
- Treatments tested
- pars plana vitrectomy
- Record updated
- 19 August 2026
Who can take part
- Age
- 40 years to 90 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 22 criteriaShow less
Who cannot take part
- patients with ocular disorders, prior treatments, or other conditions that could affect structural imaging or functional measurements
- prior retinal laser photocoagulation or photodynamic therapy
- previous or concurrent retinal detachment
- Patients considered poor highly myopic surgical candidates are also excluded, including those with myopic choroidal neovascularisation, macular scar, or complete macular atrophy according to the ATN classification
- vitreous haemorrhage
- ocular ischaemic syndrome
- corneal opacity
- uveitis
- dense cataract
- central serous chorioretinopathy
- retinal dystrophies
- macular scarring
- retinal vascular occlusion
- ungradable OCT/OCTA imaging
- Patients who are cognitively impaired or prisoners are excluded
- Participants may also be discontinued from study assessments if OCT imaging is unsatisfactory or ungradable, or if they are unable to complete functional tests such as microperimetry, contrast sensitivity testing, or M-chart assessment
Other criteria
- The target population is 30 adults with high myopia and MFS requiring vitrectomy
- inclusion critieria
- Be 40-90 years old
- Have high myopia, defined as refractive error worse than -6 dioptres and axial length longer than 26 mm
- Be mentally competent to provide informed consent
- Have MFS that meets clinical criteria for surgical intervention, specifically:progressively worsening vision that correlates with structural OCT deterioration over six months; and/or foveal detachment
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 40 and 90 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This prospective pilot study evaluates factors that predict outcomes after vitrectomy for myopic foveoschisis (MFS), a sight-threatening complication of high myopia that can lead to progressive visual loss, foveal detachment, macular holes, and retinal detachment. Although vitrectomy can relieve traction and improve retinal anatomy, the optimal timing of surgery and the factors associated with visual recovery remain uncertain, particularly in patients with relatively good pre-operative vision.
Read full original descriptionShow less
The study will recruit 30 adults aged 40-90 years from Singapore National Eye Centre surgical retina clinics. Participants must have high myopia (worse than -6 dioptres and axial length >26 mm) with MFS requiring surgery because of progressive vision loss with OCT-confirmed deterioration over six months and/or foveal detachment. Patients with other ocular diseases or conditions that could confound imaging or functional testing, poor surgical candidacy, cognitive impairment, or ungradable imaging will be excluded.
Participants will undergo standard-of-care 23- or 25-gauge pars plana vitrectomy, with fovea-sparing internal limiting membrane peeling or flap, possible gas tamponade, and cataract surgery where clinically indicated. The research does not alter the usual surgical approach; its main purpose is to collect structural and functional outcome data over 12 months.
Assessments will be performed at baseline and during postoperative follow-up, including best-corrected visual acuity, refracted logMAR visual acuity, microperimetry, M-chart testing for metamorphopsia, contrast sensitivity using the Manifold Contrast Vision Meter, and swept-source OCT. OCT measures will include central retinal thickness, foveal detachment, inner and outer macular schisis, lamellar holes, and epiretinal membrane. Demographic and clinical variables, including age, sex, co-morbidities, and lens status, will also be collected.
The primary functional outcome is stable or improved best-corrected visual acuity. Anatomical success is defined as improvement in retinoschisis and resolution of pre-existing foveal detachment. The investigators hypothesise that improvement can occur across a range of MFS severities, and that baseline OCT features and functional measures can help predict 12-month surgical success.
As a pilot study, no formal sample-size calculation is planned. Analyses will describe clinical characteristics, compare outcomes between better and poorer pre-operative visual-acuity groups, and use multivariable logistic regression to identify prognostic factors. Risks are limited to usual surgical complications and confidentiality risks; all study tests are non-invasive. Data will be securely stored, access restricted to the study team, and participants will provide informed consent.
Parallel studies will be conducted with overseas collaborators.
The group in the trial
- Predictors of Vitrectomy Outcomes in Myopic FoveoschisisExisting treatment, for comparison
pars plana vitrectomy and internal limiting membrane peel / flap in various stages of myopic foveoschisis
Treatment: pars plana vitrectomy
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Structural and Functional Determinants of Surgical Outcomes in Vitrectomy for Myopic Foveoschisis
- Criteria questions
- Built from NCT07774637, who can take part
- Record updated
- 19 August 2026